Inflammation during Lung Cancer Progression and Ethyl Pyruvate Treatment Observed by Pulmonary Functional Hyperpolarized <sup>129</sup>Xe MRI in Mice

<div>Qualitative spatial comparison of the HPXe MRI parametric maps (<i>f<sub>D</sub></i> and <i>r<sub>a</sub></i>) and histology slides obtained from two examples of LC model mice. Arrows indicate deficits in <i>f<sub>D</sub></i> that correspond spatially with the location of tumors on histology.</div>

Contrast Media & Molecular Imaging

fig5

Figure 5

Figure 5: Inflammation during Lung Cancer Progression and Ethyl Pyruvate Treatment Observed by Pulmonary Functional Hyperpolarized <sup>129</sup>Xe MRI in Mice 

Contrast Media & Molecular Imaging

Inflammation during Lung Cancer Progression and Ethyl Pyruvate Treatment Observed by Pulmonary Functional Hyperpolarized 129Xe MRI in Mice

Figure 5

Inflammation during Lung Cancer Progression and Ethyl Pyruvate Treatment Observed by Pulmonary Functional Hyperpolarized ¹²⁹Xe MRI in Mice